Hsu et al used the TriNetX platform to study the association between semaglutide use and the incidence of NAION and found that it was associated with an increased risk in patients with diabetes at the 2-, 3-, and 4-year timepoints but not within 1 year of GLP-1 RA initiation
The weight loss effect, while significant, is considered a beneficial side effect rather than the primary purpose
Your BMI is 30 or higher, and you have diastolic heart failure, high blood pressure, chronic kidney disease, prediabetes, a previous heart attack or stroke or peripheral artery disease
Coombs et al., 2021
Drinkable vials containing 200 mg of pure L-Carnitine
Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, et al